NEWS | General News | TCM News | Medical Center News | Health Archive
Current location: home>> Sino-western Joint >> LUNG ABSCESS
PART FIVE LUNG ABSCESS

Lung abscess literally means a collection of pus within a de-stroyed portion of the lung; thus there are numerous possible causes of such a lesion (Table 6). As uscd cliniclly, however, the term "lung abscess" refers to a pulmonary infection with parenchymal necrosis, generally caused by bacteria other than mycobacteria. Lung abscesses are usually solitary, but occasionally multiple dis-crete lesions are observed. Numerous small abscesses confined to a given region of the lung are sometimes referred to as "necrotizing pneumonia. "Because they share a common pathogenesis, there is considerable overlap among aspiration pneumonia, lung abscess, and necrotizing pneumonia, and each of these may lead to and coexist with an empyema(a collection of pus within the pleural space).

Etioloay As indicated in the following Table, many different underlying processes can lead to the formation of a lung abscess. By far the most important are necrotizing pulmonary infections, and of these, anaerobic bacteria are responsible for the majority. These or-ganisms account for essentially all "putrid" lung abscesses and nearly all that have been classified as "nonspecific" or "primary". Most of these infections involve multiple bacterial species, which may in-dude aerobic organisms , The dominant bacteria are Fusobacterium nucleatum, Bacteroides melaninogenicus, B. intermedius, pep-tostreptococcus, aerobic streptococci, and microaerophilic strepto-cocci.

Pneumonia, particularly cases caused by Staphylococcus aureus and Klebsiella pneumoniae, may also be complicated by abscess formation. Less frequent but well-documented agents of lung abscess include Streptococcus pyogenes(group A beta-hemolytic streptococci), Streptococcus pneumoniae (especially type 3), Streptococcus milleri, Haemophilus influenzae (type B),Pseudo-monas aeruginosa, Pseudomonas pseudomallei(me-lioidosis), Ac-tinomyces (actinomycosis), Legionella, Nocar-dia, Paragonimus Westermani (lung fluke), and Entamoeba histolytica (amebiasis), Enteric gram-negative bacilli other than K. pneumoniae may cause lung abscess, but this occurs almost exclusively in debilitated patients with severe associated medical-surgical conditions. Necrotizing alveolitis is a separate entity diagnosed by micro-scopic examination and usually caused by P. aeruginosa; sometimes these microabscesses coa-lesce to form radiographically detectable cavities.

Pathogenesis The formation of an anaerobic lung abscess nearly always involves two coexisting abnormalities: peri-odontal infection, such as gingivitis or pyorrhea, which pro-vides the inoculum; and aspiration, which provides access to the lung parenchyma. The usual causes for aspiration are those that compromise consciousness and the gag reflex, such as al-coholism, drug addiction, general anesthesia, seizure disorder, sedative use, or neurologic disorders. Other factors predispos-ing to aspiration include dysphagia resulting from esophageal disorders or neurologic deficits; disruption of the usual me-chanical barriers, as with nasogastric intubation, tracheosto-my, or nasogastric feeding tubes; or pharyngeal anesthesia, as seen with dental procedures or surgery involving the upper air-way. Most healthy persons periodically aspirate smalt inocula from the upper airways, but these are readily cleared by the normal cough reflex and other pulmonary defense mechanisms without deleterious consequences. Patients who develop aspira-tion pneumonia and lung abscesses presumably do so because of the relatively large inocula of bacteria and failure of the usual protective mechanisms.

The initial lesion is pneumonitis, or "aspiration pneumo-nia". which typically involves dependent pulmonary segments, e.g., those favored by gravitational flow. The dependent pul-monary segments in patients who aspirate in the recumbent po-sition are the superior segments of the lower lobes or posterior segments of the upper lobes. Aspiration in the upright or semi-upright position favorg involvement of the basilar segments of the lower lobes. Patients who have a defined period of known or probable aspiration demonstrate with sequential radiographs that 7 to 14 days are usually required for the appearance of typical air-fluid level on chest radiograph.

Clinical Manifestations Patients with anaerobic abscess-es tend to have indolent symptomatology with medical com-plaints dating for 2 or more weeks before presentation. The usual symptoms are fever, malaise, cough sputum production, and pleuritic pain. The frequent observation of weight loss and anemia provides testimony to the chronicity of the infection. There may be "chilliness", but frank rigors are rare, and their presence suggests organisms other than anaerobes. The cough often becomes more productive at the time of cavitation, and it is at this time that the patient is most likely to note the onset of putrid sputum, which is considered diagnostic of anaerobic infection. Putrid sputum is found in 60 per cent of patients with a confirmed anaerobic etiology. Many patients will also note that the suputm has an unusually noxious taste. Most pa-tients have a historyof compromised consciousness or other rish factors for aspiration, and many have periodontal infec-tion. Nevertheless, about 10 per cent of patients with anaero-bic lung abscesses have no identifiable predisposing condition. Occasional patients with anaerobic lung abscesses are edentu-lous; the incidence of underlying bronchogenic neoplasms seems particularly high in this group. Patients with lung ab-scesses due to S. aureus, gramnegative bacilli, and amebae usually have a more fulminant course, with the precipitous on-set of symptoms. Other features that may be noted in this group include chills, the lack of putrid discharge, and the ab-sence of the usual associated findings. The physical findings in the early phases of disease are those of pneumonia, with or without a pleural effusion. At a later stage there may be am-phoric or cavernous breath sounds, pleural effusions are com-mon, and approximately 25 per cent of patients have an associ-ated empyema.

Diagnosis The diagnosis of lung abscess is usually estab-lished on the basis of a chest radiograph showing a parenchy-mal infiltrate with a cavity containing an air-fluid level. The differential diagnosis of this roentgenographic finding is includ-ed in the above Table(Table 6). Certain roentgenographic fea-tures may provide clues to the presence of an infected cyst, bulla, or sequestration. Massive pulmonary fibrosis with necrosis from occupational exposure is usually distinctive. A loculated empyema with an air-fluid level may be differentiated from lung abscess with computed tomography.

Studies for an etiologic agent are often hampered by the limitations of bacteriologic analysis of expectorated sputum. These specimens are useful in detecting mycobacteria, pathogenic fungi, and parasites, and they may be used for cytologic studies. However, routine aerobic cultures often give erroneous results, and they are not valid for meaningful anaer-obic culture owing to the universal presence in oral secretions of anaerobes that contaminate the specimen during passage through the upper airways. Blood cultures are useful, primari-ly for patients with infections involving S. aureus or gram-neg-ative bacilli, but most patients with anaerobic abscesses do not have bacteremia. Pleural fluid is a valuable culture source for both aerobic and anaerobic bacteria in any patient with an empyema, so that thoracentesis should be performed before treatment is begun. For most patients with anaerobic pul-monary infections restricted to the pulmonary parenchyma, the preferred specimen source is from a transtracheal aspiration, from a transthoracic needle aspirate, or from a fiberoptic bron-choscopy utilizing a double-lumen catheter with a distal occlud-ing plug, combined with quantitative cultures. Specimen col-lection prior to institution of antibiotic therapy is preferred. In most cases of anaerobic abscesses, the etiologic agents will not be defined, and the therapeutic regimen will be selected empir-ically. Bronchoscopy, which used to be performed routinely in patients with lung abscesses, is now usually restricted to pa-tients who fail to respond to antibiotic treatment or who have an atypical clinical presentation. Major concerns are a cavitat-ing neoplasm, an obstructing tumor, or a foreign body.

Treatment The most important facets of the treatment are the administration of appropriate antibiotics and adequate drainage of any associated empyema. Physiotherapy with pos-rural drainage should be utilized when possible; however, this must be done with considerable caution in patients with large lung abscesses because of the possibility of spillage of purulent contents, with extensive involvement of other lobes.

The drugs of choice for the treatment of abscesses caused by aerobic pyogenie microorganisms, Mycobacterium tubercu-losis, fungi, and Entamoeba histolytica are reviewed in detail elsewhere in this volume. For aspiration-related lung abscess involving anaerobic bacteria, the three antimicrobial regimens recommended are penicillin, clindamycin, or penicillin plus metronifamodazole. Penicillin has traditionally been regarded as the favored drug on the basis of its long, well-established track record. There is considerable variation in the dosage rec-ommendations, but most authorities recommend doses of 10 to 20million units given intravenously per day. This is continued until the patient is afebrile and clinically improved, at which time treatment is changed to intramuscular or oral penicillin using penicillin G, penicillin V, ampicillin, or amoxicillin in doses of 500 to 750 mg three or four times daily. Some author-ities suggest an arbitrarily selected total duration of treatment of 3 to 6 weeks, whereas others continue treatment until the chest radiograph changes have cleared or there is only a small, stable residual lesion. The latter criterion commonly requires 2 to 4 months or longer but may be necessary to prevent relaps-es.

Clindamycin is active against most penicillin-resistant anaer-obes that are found in 20 to 25 per cent of cases, includ-ing many or most strains of B. melaninogenicus, B. fragilis, B. ruminicola, and B. ureolyticus. Some regard clindamycin as the preferred agent for all lung abscesses due to anaerobic bac-teria; others advocate it only for patients who fail to respond to penicillin, have a contraindication to penicillin, or have a seri-ous infection with a fulminant course. The usual regimen is 600 mg given intravenously every 6 to 8 hours until the patient is afebrile and clinically improved, followed by 300 mg orally four times daily. An alternative regimen is penicillin G(above doses) combined with metronidazole (2 mg orally per day in two to four divided doses). Metronidazole is active against nearly all clinically important anaerobes, but penicillin must be added owing to the probable importance of aerobic and mi-croaerophilic streptococci.

The necessity to treat the aerobic components of mixed aerobic-anaerobic infections is controversial, but this is gener-ally advo-cated for patients who are seriously ill of fail to re-spond to clindamycin. In such cases, most penicillins are con-sidered equally effective against oral anaerobes, including peni-cillin G, penicillin V, anpicillin, amoxicillin, ticarcillin, and piperacillin. However, antistaphylococcal penicillins , such as nafcillin or oxacillin, are considered inferior and unacceptable. Cephalosporins are considered nearly equivalent to penicillins in terms of in vitro activity, although the clinical experience is limited, Imipenem and any combination of a betalactam-beta-lactamase inhibitor are considered almost universally active a-gainst clinically important anaerobes. The activity of tetracy-clines and erythromycin is variable. Quinolones and trimetho-prim-sulfamethoxazole are un-acceptable for infections caused by anaerobic bacteria.

Patients with lung abscesses involving S. aureus should be treated with a penicillinase-resistant penicillin or a first-genera-tion cephalosporin. Vancomycin is the preferred agent for meth-icillin-resistant strains of S. aureus. This agent or clin-damycin may be used for patients with a contraindication to beta-lactam antibiotics. Penicillin G is the preferred agent for infections involving group A beta-hemolytic streptococcal infec-tion. Anti-biotic selection for infections involving gram-nega-tive bacilli requires in vitro sensitivity data. This usually con-sists of an aminoglycoside combined with an expanded-spec-trum penicillin, such as ticarcillin for P. aeruginosa or a cephalosporin for Enter-obacteriaceae. Sulfonamides are pre-ferred agents for Nocardia infections.

The expected response to antimicrobial agents is subjec-tive improvement with decreased fever within 3 to 7days and elimination of fever within 7 to 14 days. The putrid odor of the sputum, when initially present, usually resolves in 3 to 10 days. Delayed response may indicate large cavity size, poor host status, obstruction, erroneous antimicrobial selection, a wrong diagnosis, drug fever, a complicating empyema requir-ing drainage, of an abscess that requires drainage by physio-therapy, bronchoscopy, or surgery. Radiographic response is delayed;in fact, there is often extension of the infiltrate and increased cavity size or new cavity formation during the first week. Chest radiographs should be followed at 2 to 3 week in-tervals with the expectation that infiltrates will clear or there will be a small residual scar or a thin-walled cyst.

Bronchoscopy is indicated in patients with an atypical pre-sen-tation and in those who fail to respond to recommended an-timi-crobial regimens. The major purpose of the procedure is to differentiate cavitating neoplasms and to detect underlying lesions, such as bronchogenic neoplasms, bronchostenosis, or a foreign body. It may also be used to facilitate drainage.

The major indications for surgery are an uncontrollable or life-threatening hemorrhage, a bronchogenic neoplasm, a bronchial obstruction, or a lung abscess that proves absolutely refractory to medical treatment . Medical failures are rare but are most common in patients with an obstructed bronchus, those with extremely large abscesses, those with abscesses that have been present for an extended period before the institution of treatment , and those with infections involving certain bacte-ria such as gram-negative bacilli. The usual surgical procedure is lobectomy. Patients with prohibitive operative risks may benefit from percutaneous drain-age, but care must be taken to avoid contamination of the pleural space.

Prognosis The natural course of lung abscesses was best studied in the prechemotherapeutic era. Treatment at that time was nearly equally divided between conservative manage-ment using postural drainage and supportive care, and surgery. The mortality rate was about 33 per cent in both groups, and another third of patients developed a chronic de-bilitating disease or suffered recurrent symptoms. The avail-ability of the Jackson bronchoscope to facilitate drainage had no important bearing on outcome. The technique of resectional surgery was developed at about the time penicillin became available, and the relative merits of these two approaches as the primary therapeutic modality were widely debated. During the past two decades, however, the majority of patients have been treated with antibiotics alone, including those with "de-layed closure" (i. e. , the persistence of a cavity demonstrated by a chest radiograph at 4 to 6 weeks after the initiation of an-tibiotic therapy), because most of these cavities eventually re-solve if the antibiotics are continued long enough . The mortali-ty rate for aspiration-related lung abscess is currently reported at 5 to 6 per cent. Findings that herald a relatively poor prog-

nosis include large cavity size, particularly cavities greater than 6 cm in diameter; prolonged symptoms prior to presen-tation, especially symptoms for more than 6 weeks; necro-tizing pneumonia characterized by multiple small abscesses in contiguous segments; patients who are elderly, debilitated, or immunologically compromised; abscesses associated with bronchial obstruction; and abscess due to aerobic bacteria, including S. aureus and gram-negative bacilli.

Prevention The major preventive measures are factors used to reduce the incidence or magnitude of aspiration, appro-priate care of periodontal disease, early treatment of pneumo-nia, and adequate courses of antimicrobials to prevent relapses.

Diagnosis of Traditional Chinese Medicine

In traditional Chinese medicine, the disease is called "feiyong".

1. Medical history and onset of the disease: Pulmonary abscess due to aspiration is frequently caused by vomit resulting from coma, drunken state and esophageal and; pylonic ob-struction, or by oral inflammation and pharyngolaryngeal oper-ation, The pathogenic bacteria, carried into the lung through respiratory movements, multiply there. Hematogenous pul-monary abscess is often secondary to pyemia due to the pyo-genic infections of the skin and deep tissues, osteomyelitis, etc.

2. Clinical manifestations: The onset is abrupt withdni-tial symptoms of chills, fever, chest pain, cough, hemoptysis and the production of a large amount of purulent sputum. The sputum is viscid and fetid. At the initial stage physical exami-nation may show no obvious changes on the lung. When there is consolidation resulting from inflammation, there may be dullness on percussion. If there is a cavity formation, an am-phoric sound may be elicited on percussion.

3. In blood examination leukocyte count is markedly in-creased up to 20*10/L—30*10/L, increased neutrophil with a shift to left. In hemato genous pulmonary abscess blood culture may be positive and pathogenic bacteria can be identi-fied. Bloody sputum culture and antimicrobial sensitive test should be done, which are helpful for selecting effective antibi-otics. Chest X-ray examination is useful for discovering early lesions. Aspiration pulmonary abscess in mostly located in the posterior segment of the right upper lobe and apical segment of the right lower lobe. At the initial stage there is a large area of consolidation. When abscess or abscess cavity is formed, fluid level within it can be seen. In hematogenous pulmonary ab-scess, many small dense shadows or globular shadows or thin-wall cavities in both left and right middle and lower lobes may be present. Computerized tomography is helpful in making correct diagnosis and in identifying the degree of involvement of the bronchi.

Differentiation and Treatiment of Common Syndromes in Traditional Chinese Medicne

1. The Primary Stage:

Clinical manifestations: Chills, fever, cough, chest pain, small amount of mucous sputum, disturbance of breath, thin and yellowish coating of the tongue, floating and rapid pulse.

Therapeutic method : Clearing away and dispelling lungheat and removing toxic substances from the lung.

Recipe: Modified Powder of Lonicera and Forsythia.

Ingredients :

Flos Lonicerae 30g

Fructus Forsythiae 15g

Folium Isatidis 15g

Radix Scutellariae 12g

Herba Taraxaci 30g

Herba Menthae 10g

Herba Houttuyniae 30g

Bulbus Fritillariae Cirrhosae 10g

Radix Platycodi 10g

Administration: All the above drugs are to be decocted in water for oral administration.

Modification: In case of chest pain, add Fructus Tri-chosanthis 20g, Radix Curcumae 12g.

2. The Abscess-forming Stage:

Clinical manifestations: Fever, cough with dyspnea, chest fullness, chest pain, productive cough, polypnea, dry mouth without thirst, reddened tongue with yellow greasy fur, and smooth rapid pulse.

Therapeutic method: Removing pathogenic heat and toxic materials.

Recipe: Modified Reed Rhizome Decoction Worth a Thousand Gold.

Ingredients:

Rhizoma Phragmitis 30g

Semen Coicis 30g

Semen Benineasae 24g

Semen Persicae 10g

Flos Lonicerae 15g

Fructus Forsythiae 15g

Radix Scutellariae 12g

Herba Houttuyniae 30g

Fructus Trichosanthis 20g

Radix Platycodi 10g

Radix Glycyrrhizae 6g

Administration: All the above drugs are to be decocted in water for oral administration.

Modification: In case of the patients with high fever and thirst, add Gypsum Fibrosum 30g and Rhizoma Anemarrhenae 10g; in case of persisting high fever, add Herba Taraxaci 30g; Herba Violae 15g and Fructus Gardeniae 10g; in case of pro-fuse hemoptysis, add Radix Rehmanniae 20g and Rhizoma Bletillae 12g; in case of profuse sputum and dyspnea with chest distensin, add Cortex Mori Radicis 12g and Semen Lep-idii seu Descurainiae 10g.

3. The Abscess-bursting Stage:

Clinical manifestations: Coughing out a large quantity of fetid and purulent sputum, sometimes mixed with blood, chest pain, stuffiness and distension in the chest, slow lysis of fever, red tongue with yellow and greasy fur, deep and force-ful or slippery and rapid pulse.

Therapeutic method: Draining pus and removing the poi-sonous substanses.

Recipe: Decoction of Platycodon Root with additional in-gredients.

Ingredients:

Radix Platycodi 15g

Semen Coicis 20g

Herba Houttuyniae 30g

Herba Patriniae 30g

Caulis Sargentodoxae 30g

Semen Benincasae 30g

Bulbus Fritillariae Thunbergii 15g

Flos Lonicerae 30g

Radix Glycyrrhizae 6g

Administration: Decoct the above drugs in water to get 200-300ml of decoction. Take one half of it in the morning and the other half in the evening.

Modification: If the case in the restoration stage is accom-panied with impaired qi and yin manifested as low fever, weakness, cough with little sputum, and expectorating persis-tently purulent blood, spontaneous perspiration and night sweat, red tongue with little fur, fine and rapid pulse, it is suitable to aim the treatment at nourishing qi and yin and clearing away the remaining poisonous substances. The chosen recipe is Modified prescriptions of Decoction of Glehnia and Ophiopogon and Pulse-activating Powder.

Ingredients:

Radix Glehniae 15g

Radix Ophiopogonis 15g

Radix Pseudostellariae 12g

Radix Astragali seu Hedysari 12g

Semen Benincasae 20g

Radix Platycodi 12g

Rhizoma Bletillae 12g

Radix Rehmanniae 15g

Flos Lonicerae 15g

Radix Glycyrrhizae Praeparata 6g

Please comment here.
Name: E-Mail:
*
Comment made on this article doesn't stand for the position of TCMADVISORY.
...
Copyright©2003,Guilin Sino-western Joint Hospital Chinese Medicine Advisory Department
About Us | TCM | Reflexology | Acupuncture | Taiji | Qigong | Herbal Tea | Products | Advertise | Contact us | Links | Site Map
Tel: +86-773-5820588
Fax: +86-773-5845295
E-mail: tcmadvisory@gx163.net tcmadvisory@yahoo.com
GuiLin ICP No.06002452